Ads
related to: mild intermittent vs persistent asthma- Asthma Self-Assessment
Take The Quiz To Better Understand
Your Asthma & Treatment Options.
- Get Prescription
See If You're Eligible For This
Asthma Inhaler Option.
- Sign Up To Save
You May Pay As Little As $0 On This
Asthma Treatment If Eligible.
- Access FAQ
View Frequently Asked Questions
About Asthma & This Treatment.
- Asthma Self-Assessment
Search results
Results From The WOW.Com Content Network
"Asthma can be episodic or chronic as it affects people differently with some people only having intermittent mild symptoms and other people having chronic severe symptoms," says Dr. Joshua ...
Its use may result in undertreatment, as treatments for asthma, chronic bronchitis, emphysema, or pneumonia may not be prescribed under a label of reactive airway disease. [1] Alternatively, overtreatment may occur, as patients can be prescribed inhaled beta-agonists or inhaled corticosteroids , which are medications used for asthma.
Asthma phenotyping and endotyping has emerged as a novel approach to asthma classification inspired by precision medicine which separates the clinical presentations of asthma, or asthma phenotypes, from their underlying causes, or asthma endotypes. The best-supported endotypic distinction is the type 2-high/type 2-low distinction.
Due to their fast onset of action, they have been selected as first-line therapy for quick relief in persistent and intermittent asthma and bronchospasm. [6] Patients may experience dizziness, heart palpitations, hyperglycemia, diarrhea and muscle cramps when taking these medications.
Asthma is a common pulmonary condition defined by chronic inflammation of respiratory tubes, tightening of respiratory smooth muscle, and episodes of bronchoconstriction. [1] The Centers for Disease Control and Prevention estimate that 1 in 11 children and 1 in 12 adults have asthma in the United States of America. [ 1 ]
Asthma phenotyping and endotyping is a novel approach to asthma classification inspired by precision medicine.It seeks to separate the clinical presentations or clusters of signs and symptoms of asthma, known as asthma phenotypes, from their underlying etiologies or causes, known as asthma endotypes.
Ad
related to: mild intermittent vs persistent asthma